AngioDynamics competitors

Michael F. Mahoney is a Director on the board of the Boys & Girls Club of Boston. He is the Chairman and CEO of Boston Scientific.

Michael A. Mussallem, age 56, has been chairman and CEO of Edwards Lifesciences, Inc. since 2000. Prior to 2000, Mussallem held a variety of positions with increasing responsibility in engineering, product development and senior management at Baxter International Inc., including Group Vice President of its CardioVascular business from 1994 to 2000 and Group Vice President of the Biopharmaceutical business from 1998 to 2000. From 1996 until 1998, he was the Chairman of Baxter's Asia Board overseeing Baxter's operations throughout Asia. Mr. Mussallem is chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed), and serves as a member of the board for Advanced Medical Optics. He is also on the boards and executive committees of the California Healthcare Institute and OCTANe, and is a trustee of the University of California, Irvine Foundation. He received a bachelor's degree in chemical engineering in 1974 and an honorary doctorate in 1999 from the Rose-Hulman Institute of Technology in Indiana.

Liam became President and CEO on January 1, 2018. He joined Teleflex in April 2009 and shortly thereafter assumed responsibility as President of EMEA. He was then promoted to the position of Executive Vice President and President, International in June 2012. In April 2014, Liam was appointed Executive Vice President and President, Americas. In April 2015, he was named Executive Vice President and Chief Operating Officer. From May 2016 to December 2017, he served as President and Chief Operating Officer. Prior to joining Teleflex, Liam worked at Hill-Rom where he held senior leadership positions from 2002 to 2009. He was the Vice President of International Marketing and Product Development and previously had been Managing Director of their UK & Ireland businesses. Liam holds a Bachelor of Business Studies from the University of Limerick.

EXECUTIVE with successful career in CPG space with specific emphasis in Food products. Combination of experience in Private Equity (past 13 years) and Public companies. Strong track record of leading teams to a common, successful goal, including successful exits through private equity. Currently serving as President leading the transition from private equity owned to a public company. Experience developing and leading long-term planning and strategic direction with the senior management team. Team-oriented individual with strong desire to make the organization and individuals within the organization successful. Specialties: Team development, proven turnaround expereince, creation of effective metric reporting, driven, influential leader

Geoff Martha is firmly establishing Medtronic as the undisputed global leader in healthcare technology. As chairman & CEO, Geoff leads the $30 billion company and its 90,000 employees in pursuit of fulfilling the Medtronic Mission to use technology to improve human welfare. He is recognized as a driven and innovative executive - ranking in Modern Healthcare’s 100 Most Influential People in Healthcare in 2020 and listed as the #1 CEO in healthcare technology by the Healthcare Technology Report in 2021.Geoff became CEO in April 2020. Under his leadership, Medtronic is putting the ‘tech’ in MedTech, leveraging the latest advances in cutting edge technology to transform healthcare. Fortune Magazine named Medtronic among the top 15 companies for its 2020 “Change the World” list, recognizing its swift efforts during the pandemic, and listed the company on its 2021 list of Most Admired Companies.Geoff joined Medtronic in 2011, and notably led the acquisition and integration of Covidien, the largest acquisition in the medical technology industry. Before joining Medtronic, Geoff spent 19 years at GE Healthcare and GE Capital.Geoff is a member of the Business Roundtable, and the World Economic Forum’s International Business Council. He also co-chairs the Taskforce on Health and Life Sciences for B20, a G20 engagement group.An ardent supporter of philanthropic and diversity initiatives, Geoff serves on the board of directors for the Medtronic Foundation, Children’s HeartLink, and the Northside Achievement Zone. He is part of OneTen, a coalition of cross-industry leaders committed to breaking down systemic barriers for Black Americans. He also serves as Medtronic’s Executive Sponsor to FIRST Robotics.Geoff received a bachelor’s degree in Finance from Pennsylvania State University, where he currently serves on the Development Council for its College of Liberal Arts. He was also captain of the Penn State men’s hockey team and later inducted into its Hockey Hall of Fame.

Halsey Cook is a President/CEO at Milliken & Co and is based in Charleston, South Carolina. He has worked as Marketing Director at Carrier; Managing Director, UK at Carrier; and President at Sonepar. Halsey attended University of Virginia Darden School of Business between 1989 and 1991 and Sewanee: The University of the South between 1981 and 1985.